ReviewJournal of nanobiotechnology2026
Microenvironment engineering with injectable hydrogel-based biofunctional scaffolds for augmenting bone defect regeneration.
Review in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biomedical Hydrogels Based on Natural Polysaccharides: Structural Design.Gels (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Bone defects are common injuries in the clinic that often require the use of bone grafts to facilitate bone regeneration. However, the application of bone grafts is challenged by invasive surgeries, insufficient bone regeneration capability and limited availability, necessitating the development of substituting materials with enhanced safety, osteogenic capacity and large-scale applicability. Interestingly, injectable hydrogels emerge as a promising candidate for bone defect repair on account of their intrinsic biocompatibility, biomimetic structures, in-situ morphological malleability and versatile functionality. Herein, a comprehensive account is provided on the development of injectable hydrogel-based biomaterials and their application as scaffolds for supporting and guiding bone defect healing, focusing on the gelling mechanisms as well as their potential osteoinductive properties through (1) establishing osteoinductive microenvironment and (2) localized delivery of osteogenic therapeutics for boosting osteogenesis. Furthermore, existing challenges and potential breakthroughs in injectable hydrogel-based biofunctional scaffolds for bone defect treatment are discussed in-depth, focusing on the leveraging their therapeutic persistence and degradability, cost-effectiveness and dynamic material-biointeractions. It is anticipated that the insights in this review may provide new opportunities for minimally invasive bone defect treatment in the clinic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.